ArticleCase reports in gastrointestinal medicine2026
Gastric Perforation as a Manifestation of Sarcoidosis: A Case Report.
Article in Case reports in gastrointestinal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastrointestinal involvement in sarcoidosis is rare, and clinically apparent disease occurs in fewer than 1% of patients. The stomach is the most frequently affected site, although presentations are usually indolent. Perforation is exceedingly rare, and to our knowledge, this is the first case of gastric perforation attributable to sarcoidosis. Case Presentation: A 30-year-old woman presented with 4 months of bilateral lower extremity paresthesia, pleuritic chest pain, progressive dyspnea, abdominal discomfort, and 50 lb unintentional weight loss. Angiotensin-converting enzyme and soluble interleukin-2 receptor were markedly elevated, and autoimmune serologies and extensive infectious workup were negative. Imaging revealed abdominal and pelvic lymphadenopathy, hepatosplenomegaly, and bilateral cavitary pulmonary opacities with mediastinal and hilar lymphadenopathy.During admission, she developed acute abdominal pain with pneumoperitoneum. Emergent laparotomy revealed a 6-mm gastric perforation repaired with a Graham patch, with biopsies revealing lymphohistiocytic aggregates and multinucleated giant cells containing asteroid bodies. Subsequent endobronchial ultrasound-guided mediastinal node biopsy demonstrated granulomatous lymphadenitis, and a bronchoalveolar lavage showed a cD4/CD8 ratio of 15:1, suggesting sarcoidosis. Glucocorticoids were deferred due to surgical repair initially, and hydroxychloroquine was started. Subsequent lung wedge resection confirmed non-necrotizing granulomas. Mycophenolate mofetil was then added and replaced by methotrexate with clinical improvement and resolution of symptoms. Conclusion: Gastric perforation can be a severe complication in sarcoidosis, particularly in patients with multisystemic symptoms that are not otherwise explained. Multidisciplinary involvement is needed to appropriately treat these patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.